Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

496 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
New concepts in the management of dyslipidaemiaa.
Gencer B, Rodondi N, Mach F. Gencer B, et al. Among authors: rodondi n. Swiss Med Wkly. 2016 Nov 12;146:w14378. doi: 10.4414/smw.2016.14378. eCollection 2016. Swiss Med Wkly. 2016. PMID: 27878791 Free article.
Eligibility for PCSK9 Inhibitors According to American College of Cardiology (ACC) and European Society of Cardiology/European Atherosclerosis Society (ESC/EAS) Guidelines After Acute Coronary Syndromes.
Gencer B, Koskinas KC, Räber L, Karagiannis A, Nanchen D, Auer R, Carballo D, Carballo S, Klingenberg R, Heg D, Matter CM, Lüscher TF, Rodondi N, Mach F, Windecker S. Gencer B, et al. Among authors: rodondi n. J Am Heart Assoc. 2017 Nov 9;6(11):e006537. doi: 10.1161/JAHA.117.006537. J Am Heart Assoc. 2017. PMID: 29122809 Free PMC article.
Thyroid hormones treatment for subclinical hypothyroidism: a clinical practice guideline.
Bekkering GE, Agoritsas T, Lytvyn L, Heen AF, Feller M, Moutzouri E, Abdulazeem H, Aertgeerts B, Beecher D, Brito JP, Farhoumand PD, Singh Ospina N, Rodondi N, van Driel M, Wallace E, Snel M, Okwen PM, Siemieniuk R, Vandvik PO, Kuijpers T, Vermandere M. Bekkering GE, et al. Among authors: rodondi n. BMJ. 2019 May 14;365:l2006. doi: 10.1136/bmj.l2006. BMJ. 2019. PMID: 31088853
Control of cardiovascular risk factors and health behaviors in patients post acute coronary syndromes eligible for protein convertase subtilisin/kexin-9 inhibitors.
Butty A, Gencer B, Koskinas KC, Carballo D, Räber L, Klingenberg R, Matter CM, Lüscher TF, Windecker S, Muller O, Rodondi N, Mach F, Nanchen D. Butty A, et al. Among authors: rodondi n. Int J Cardiol. 2020 Jan 15;299:289-295. doi: 10.1016/j.ijcard.2019.10.012. Epub 2019 Oct 9. Int J Cardiol. 2020. PMID: 31668506
Intensified lipid lowering using ezetimibe after publication of the IMPROVE-IT trial: A contemporary analysis from the SPUM-ACS cohort.
Gencer B, Carballo D, Nanchen D, Koskinas KC, Klingenberg R, Räber L, Auer R, Carballo S, Heg D, Windecker S, Lüscher TF, Matter CM, Rodondi N, Mach F. Gencer B, et al. Among authors: rodondi n. Int J Cardiol. 2020 Mar 15;303:8-13. doi: 10.1016/j.ijcard.2019.12.011. Epub 2019 Dec 10. Int J Cardiol. 2020. PMID: 31859113 Clinical Trial.
Eligibility for PCSK9 inhibitors based on the 2019 ESC/EAS and 2018 ACC/AHA guidelines.
Koskinas KC, Gencer B, Nanchen D, Branca M, Carballo D, Klingenberg R, Blum MR, Carballo S, Muller O, Matter CM, Lüscher TF, Rodondi N, Heg D, Wilhelm M, Räber L, Mach F, Windecker S. Koskinas KC, et al. Among authors: rodondi n. Eur J Prev Cardiol. 2021 Mar 23;28(1):59-65. doi: 10.1177/2047487320940102. Epub 2020 Jul 20. Eur J Prev Cardiol. 2021. PMID: 33755142
PCSK9 inhibitors and ezetimibe for the reduction of cardiovascular events: a clinical practice guideline with risk-stratified recommendations.
Hao Q, Aertgeerts B, Guyatt G, Bekkering GE, Vandvik PO, Khan SU, Rodondi N, Jackson R, Reny JL, Al Ansary L, Van Driel M, Assendelft WJJ, Agoritsas T, Spencer F, Siemieniuk RAC, Lytvyn L, Heen AF, Zhao Q, Riaz IB, Ramaekers D, Okwen PM, Zhu Y, Dawson A, Ovidiu MC, Vanbrabant W, Li S, Delvaux N. Hao Q, et al. Among authors: rodondi n. BMJ. 2022 May 4;377:e069066. doi: 10.1136/bmj-2021-069066. BMJ. 2022. PMID: 35508320
496 results